Alyeska Investment Group’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.22M Buy
+150,431
New +$6.59M 0.02% 435
2025
Q1
Sell
-589,848
Closed -$15M 641
2024
Q4
$15M Hold
589,848
0.06% 291
2024
Q3
$16.7M Sell
589,848
-124,556
-17% -$3.45M 0.09% 254
2024
Q2
$18.8M Sell
714,404
-437,367
-38% -$12.1M 0.11% 219
2024
Q1
$35M Buy
1,151,771
+130,735
+13% +$3.85M 0.22% 156
2023
Q4
$28.7M Sell
1,021,036
-207,209
-17% -$5.69M 0.19% 157
2023
Q3
$33.3M Sell
1,228,245
-192,825
-14% -$5.73M 0.23% 154
2023
Q2
$43.7M Buy
1,421,070
+782,676
+123% +$26.5M 0.33% 100
2023
Q1
$23M Buy
638,394
+125,367
+24% +$4.65M 0.2% 142
2022
Q4
$20.3M Buy
+513,027
New +$21.4M 0.21% 148
2022
Q3
Sell
-354,729
Closed -$14.9M 472
2022
Q2
$14.9M Buy
354,729
+281,335
+383% +$11.5M 0.17% 173
2022
Q1
$2.86M Buy
+73,394
New +$2.88M 0.03% 379
2021
Q4
Sell
-125,000
Closed -$4.52M 716
2021
Q3
$4.52M Sell
125,000
-226,597
-64% -$8.81M 0.06% 348
2021
Q2
$14.4M Buy
351,597
+25,000
+8% +$1.06M 0.17% 169
2021
Q1
$14.2M Sell
326,597
-437,220
-57% -$20.7M 0.19% 156
2020
Q4
$38.2M Buy
763,817
+260,082
+52% +$11M 0.58% 47
2020
Q3
$21.2M Buy
503,735
+68,540
+16% +$2.94M 0.35% 97
2020
Q2
$21.1M Buy
+435,195
New +$21.5M 0.32% 113

Other funds holding RPRX